PROSPECTS FOR USING COLCHICINE IN MEDICINE: NEW EVIDENCE-Reference-Cited by-同舟云学术

PROSPECTS FOR USING COLCHICINE IN MEDICINE: NEW EVIDENCE

Published:2020-04-27 Issue:2 Volume:58 Page:183-190
ISSN:1995-4492
Container-title:Rheumatology Science and Practice
language:
Short-container-title:Naučno-praktičeskaâ revmatologiâ

Author:

Alekberova Z. S.¹^ORCID,Nasonov E. L.²^ORCID

Affiliation:

1. V.A. Nasonova Research Institute of Rheumatology

2. V.A. Nasonova Research Institute of Rheumatology; I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Publisher

Mediar Press

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference108 articles.

1. Kuek A, Hazleman BL, Ostor AJ. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J. 2007;83(978):251-60. doi: 10.1136/pgmj.2006.052688

2. Theofilopoulos AN, Kono DH, Baccala R. The multiple pathways to autoimmunity. Nat Immunol. 2017;18(7):716-24. doi: 10.1038/ni.3731

3. Manthiram K, Zhou Q, Aksentijevich I, Kastner DL. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat Immunol. 2017;18(8):832-42. doi: 10.1038/ni.3777

4. McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. 2006;3:1242-8. doi: 10.1371/journal.pmed.0030297

5. Kahlenberg JM, Kang I. Clinicopathologic significance of inflammasome activation in autoimmune diseases. Arthritis Rheum. 2019 Sep 28. doi: 10.1002/art.41127

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects;Rheumatology Science and Practice;2024-02-29

2. Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease;Rheumatology Science and Practice;2023-06-28

3. Therapy of pericarditis with colchicine, interleukin-1 antagonists, immunosuppressants;Clinical Medicine (Russian Journal);2023-03-26

4. Problems of immunopathology and prospects for pharmacotherapy of idiopathic recurrent pericarditis: Using an interleukin 1 inhibitor (Anakinra);Rheumatology Science and Practice;2023-03-03

5. Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia;Rheumatology Science and Practice;2021-07-15